Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 205 to 208 of 208 entries
Sorted by: Best Match Show Resources per page
A role of the norepinephrine system or effort in the interplay of different facets of inhibitory control.

Neuropsychologia

Yu S, Ghin F, Mückschel M, Ziemssen T, Stock AK, Beste C.
PMID: 34998865
Neuropsychologia. 2022 Jan 05;166:108143. doi: 10.1016/j.neuropsychologia.2022.108143. Epub 2022 Jan 05.

Inhibitory control has multiple facets, and one possible distinction can be made between 'inhibition of interferences' and the 'inhibition of actions'. Both facets of inhibitory control show an interdependency. Even though some neurophysiological processes underlying this interdependency have been...

Cite
Yu S, Ghin F, Mückschel M, et al. A role of the norepinephrine system or effort in the interplay of different facets of inhibitory control. Neuropsychologia. 2022;166:108143doi: 10.1016/j.neuropsychologia.2022.108143.
Yu, S., Ghin, F., Mückschel, M., Ziemssen, T., Stock, A. K., & Beste, C. (2022). A role of the norepinephrine system or effort in the interplay of different facets of inhibitory control. Neuropsychologia, 166108143. https://doi.org/10.1016/j.neuropsychologia.2022.108143
Yu, Shijing, et al. "A role of the norepinephrine system or effort in the interplay of different facets of inhibitory control." Neuropsychologia vol. 166 (2022): 108143. doi: https://doi.org/10.1016/j.neuropsychologia.2022.108143
Yu S, Ghin F, Mückschel M, Ziemssen T, Stock AK, Beste C. A role of the norepinephrine system or effort in the interplay of different facets of inhibitory control. Neuropsychologia. 2022 Jan 05;166:108143. doi: 10.1016/j.neuropsychologia.2022.108143. Epub 2022 Jan 05. PMID: 34998865.
Copy Download .nbib Format: NLM
Post-intensive care syndrome in patients surviving COVID-19.

Annals of physical and rehabilitation medicine

Daste C, Ficarra S, Dumitrache A, Cariou A, Lefèbvre A, Pène F, Roche N, Roren A, Thery C, Vidal J, Nguyen C, Rannou F, Lefèvre-Colau MM.
PMID: 34182168
Ann Phys Rehabil Med. 2021 Nov;64(6):101549. doi: 10.1016/j.rehab.2021.101549. Epub 2021 Jun 26.

No abstract available.

Cite
Daste C, Ficarra S, Dumitrache A, et al. Post-intensive care syndrome in patients surviving COVID-19. Ann Phys Rehabil Med. 2021;64(6):101549doi: 10.1016/j.rehab.2021.101549.
Daste, C., Ficarra, S., Dumitrache, A., Cariou, A., Lefèbvre, A., Pène, F., Roche, N., Roren, A., Thery, C., Vidal, J., Nguyen, C., Rannou, F., & Lefèvre-Colau, M. M. (2021). Post-intensive care syndrome in patients surviving COVID-19. Annals of physical and rehabilitation medicine, 64(6), 101549. https://doi.org/10.1016/j.rehab.2021.101549
Daste, Camille, et al. "Post-intensive care syndrome in patients surviving COVID-19." Annals of physical and rehabilitation medicine vol. 64,6 (2021): 101549. doi: https://doi.org/10.1016/j.rehab.2021.101549
Daste C, Ficarra S, Dumitrache A, Cariou A, Lefèbvre A, Pène F, Roche N, Roren A, Thery C, Vidal J, Nguyen C, Rannou F, Lefèvre-Colau MM. Post-intensive care syndrome in patients surviving COVID-19. Ann Phys Rehabil Med. 2021 Nov;64(6):101549. doi: 10.1016/j.rehab.2021.101549. Epub 2021 Jun 26. PMID: 34182168; PMCID: PMC8233854.
Copy Download .nbib Format: NLM
Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair.

Carbohydrate polymers

Guo W, Douma L, Hu MH, Eglin D, Alini M, Šećerović A, Grad S, Peng X, Zou X, D'Este M, Peroglio M.
PMID: 34893245
Carbohydr Polym. 2022 Feb 01;277:118828. doi: 10.1016/j.carbpol.2021.118828. Epub 2021 Oct 29.

Hyaluronic acid (HA) is a key component of the intervertebral disc (IVD) that is widely investigated as an IVD biomaterial. One persisting challenge is introducing materials capable of supporting cell encapsulation and function, yet with sufficient mechanical stability. In...

Cite
Guo W, Douma L, Hu MH, et al. Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair. Carbohydr Polym. 2021;277:118828doi: 10.1016/j.carbpol.2021.118828.
Guo, W., Douma, L., Hu, M. H., Eglin, D., Alini, M., Šećerović, A., Grad, S., Peng, X., Zou, X., D'Este, M., & Peroglio, M. (2022). Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair. Carbohydrate polymers, 277118828. https://doi.org/10.1016/j.carbpol.2021.118828
Guo, Wei, et al. "Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair." Carbohydrate polymers vol. 277 (2022): 118828. doi: https://doi.org/10.1016/j.carbpol.2021.118828
Guo W, Douma L, Hu MH, Eglin D, Alini M, Šećerović A, Grad S, Peng X, Zou X, D'Este M, Peroglio M. Hyaluronic acid-based interpenetrating network hydrogel as a cell carrier for nucleus pulposus repair. Carbohydr Polym. 2022 Feb 01;277:118828. doi: 10.1016/j.carbpol.2021.118828. Epub 2021 Oct 29. PMID: 34893245.
Copy Download .nbib Format: NLM
Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.

Breast cancer research and treatment

Nyrop KA, Damone EM, Deal AM, Wheeler SB, Charlot M, Reeve BB, Basch E, Shachar SS, Carey LA, Reeder-Hayes KE, Dees EC, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, Wood WA, Muss HB.
PMID: 34739658
Breast Cancer Res Treat. 2022 Jan;191(2):409-422. doi: 10.1007/s10549-021-06439-6. Epub 2021 Nov 05.

PURPOSE: It is not known whether chemotherapy-related symptom experiences differ between Black and White women with early breast cancer (Stage I-III) receiving current chemotherapy regimens and, in turn, influences dose delay, dose reduction, early treatment discontinuation, or hospitalization.METHODS: Patients...

Cite
Nyrop KA, Damone EM, Deal AM, et al. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2021;191(2):409-422doi: 10.1007/s10549-021-06439-6.
Nyrop, K. A., Damone, E. M., Deal, A. M., Wheeler, S. B., Charlot, M., Reeve, B. B., Basch, E., Shachar, S. S., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., Reinbolt, R. E., Speca, J. C., Wood, W. A., & Muss, H. B. (2022). Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast cancer research and treatment, 191(2), 409-422. https://doi.org/10.1007/s10549-021-06439-6
Nyrop, K A, et al. "Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer." Breast cancer research and treatment vol. 191,2 (2022): 409-422. doi: https://doi.org/10.1007/s10549-021-06439-6
Nyrop KA, Damone EM, Deal AM, Wheeler SB, Charlot M, Reeve BB, Basch E, Shachar SS, Carey LA, Reeder-Hayes KE, Dees EC, Jolly TA, Kimmick GG, Karuturi MS, Reinbolt RE, Speca JC, Wood WA, Muss HB. Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer. Breast Cancer Res Treat. 2022 Jan;191(2):409-422. doi: 10.1007/s10549-021-06439-6. Epub 2021 Nov 05. PMID: 34739658.
Copy Download .nbib Format: NLM
Showing 205 to 208 of 208 entries